Helen E. Collins Laboratory

Investigating Mechanisms Underlying Female Cardiovascular Resilience and Health

Cardiomyocyte stromal interaction molecule 1 is a key regulator of Ca2+‐dependent kinase and phosphatase activity in the mouse heart


Journal article


Helen E Collins, Joshua C. Anderson, Adam R. Wende, John C. Chatham
Physiological reports, 2022

Semantic Scholar DOI PubMedCentral PubMed
Cite

Cite

APA   Click to copy
Collins, H. E., Anderson, J. C., Wende, A. R., & Chatham, J. C. (2022). Cardiomyocyte stromal interaction molecule 1 is a key regulator of Ca2+‐dependent kinase and phosphatase activity in the mouse heart. Physiological Reports.


Chicago/Turabian   Click to copy
Collins, Helen E, Joshua C. Anderson, Adam R. Wende, and John C. Chatham. “Cardiomyocyte Stromal Interaction Molecule 1 Is a Key Regulator of Ca2+‐Dependent Kinase and Phosphatase Activity in the Mouse Heart.” Physiological reports (2022).


MLA   Click to copy
Collins, Helen E., et al. “Cardiomyocyte Stromal Interaction Molecule 1 Is a Key Regulator of Ca2+‐Dependent Kinase and Phosphatase Activity in the Mouse Heart.” Physiological Reports, 2022.


BibTeX   Click to copy

@article{helen2022a,
  title = {Cardiomyocyte stromal interaction molecule 1 is a key regulator of Ca2+‐dependent kinase and phosphatase activity in the mouse heart},
  year = {2022},
  journal = {Physiological reports},
  author = {Collins, Helen E and Anderson, Joshua C. and Wende, Adam R. and Chatham, John C.}
}

Abstract

Stromal interaction molecule 1 (STIM1) is a major regulator of store‐operated calcium entry in non‐excitable cells. Recent studies have suggested that STIM1 plays a role in pathological hypertrophy; however, the physiological role of STIM1 in the heart is not well understood. We have shown that mice with a cardiomyocyte deletion of STIM1 (crSTIM1−/−) develop ER stress, mitochondrial, and metabolic abnormalities, and dilated cardiomyopathy. However, the specific signaling pathways and kinases regulated by STIM1 are largely unknown. Therefore, we used a discovery‐based kinomics approach to identify kinases differentially regulated by STIM1. Twelve‐week male control and crSTIM1−/− mice were injected with saline or phenylephrine (PE, 15 mg/kg, s.c, 15 min), and hearts obtained for analysis of the Serine/threonine kinome. Primary analysis was performed using BioNavigator 6.0 (PamGene), using scoring from the Kinexus PhosphoNET database and GeneGo network modeling, and confirmed using standard immunoblotting. Kinomics revealed significantly lower PKG and protein kinase C (PKC) signaling in the hearts of the crSTIM1−/− in comparison to control hearts, confirmed by immunoblotting for the calcium‐dependent PKC isoform PKCα and its downstream target MARCKS. Similar reductions in crSTIM1−/− hearts were found for the kinases: MEK1/2, AMPK, and PDPK1, and in the activity of the Ca2+‐dependent phosphatase, calcineurin. Electrocardiogram analysis also revealed that crSTIM1−/− mice have significantly lower HR and prolonged QT interval. In conclusion, we have shown several calcium‐dependent kinases and phosphatases are regulated by STIM1 in the adult mouse heart. This has important implications in understanding how STIM1 contributes to the regulation of cardiac physiology and pathophysiology.